Verition Fund Management
EVFM

Verition Fund Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Verition Fund Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$362K – 1874
2020
Q4 		$362K Buy
+10,000
New +$362K ﹤0.01% 768

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's EVFM Position: Q1 2021 in Review

Verition Fund Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2021, closing a stake of 10,000 shares — an estimated $362K sold.

Verition Fund Management first reported a position in EVFM in Q4 2020 and held it in 1 quarter. The position peaked at $362K in Q4 2020. 103 funds tracked by Wall St. Rank hold EVFM as of Q1 2021.

  • Verition Fund Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Verition Fund Management sold 10,000 Evofem Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $362K.
  • Verition Fund Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Verition Fund Management's Evofem Biosciences, Inc. Common Stock position peaked at $362K in Q4 2020.
  • 103 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2021.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.